Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$304,985,883
+$2,163,627 QoQ
Shares Held
2,373,431
-5.7% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#99
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$14,364
PutShares
11,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $3,273,366,479 across 12 Drug Manufacturers - General names. MRK ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,068,333 | $1,033,234,532 | |
| 2 | LLY |
ELI LILLY & Co
|
580,460 | $696,221,195 | |
| 3 | ABBV |
AbbVie Inc.
|
1,707,786 | $429,747,269 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
2,373,431 | $304,985,883 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,033,130 | $256,865,644 | |
| 6 | AZN |
Astrazeneca PLC
|
1,328,471 | $251,904,671 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,064,284 | $118,944,044 | |
| 8 | PFE |
Pfizer Inc
|
3,938,865 | $94,847,869 |
All Filings in MRK
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,364 | 11,400 | Put | Sole | 2026-08-13 | |
| 2026-06-30 | $304,985,883 | 2,373,431 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $302,822,256 | 2,517,435 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $154,204,321 | 1,464,985 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $98,593,913 | 1,174,716 | Shares | Sole | 2025-11-13 | |
| 2025-09-30 | $26,445 | 12,300 | Put | Sole | 2025-11-13 | |
| 2025-06-30 | $84,177,952 | 1,063,390 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $105,372,315 | 1,173,934 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $176,761,336 | 1,776,853 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $259,936,228 | 2,288,977 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $289,581,322 | 2,339,106 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $288,855,307 | 2,189,127 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $217,525,861 | 1,995,284 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $174,624,510 | 1,696,207 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $203,330,334 | 1,762,114 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $270,007,074 | 2,537,899 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $276,364,689 | 2,490,894 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $213,436,621 | 2,478,363 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $216,841,280 | 2,378,428 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $176,257,102 | 2,148,167 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $164,446,984 | 2,145,707 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $149,120,539 | 1,985,362 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $148,747,568 | 1,912,660 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $150,606,111 | 1,953,639 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $176,450,291 | 2,157,095 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $191,329,738 | 2,306,566 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $143,009,369 | 1,849,338 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $142,915,451 | 1,857,493 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||